Nichola Davies

Nichola Davies completed her PhD studies in physical organic chemistry at the University of Cambridge, utilising NMR spectroscopy to investigate positively cooperative binding and the tightening of non-covalent bonds. Nichola then joined Pfizer (Sandwich, UK) as an NMR spectroscopist supporting the medicinal chemistry department, and implemented new techniques for structure elucidation and the application of novel NMR methodologies to support medicinal chemistry design strategies.

Having gained further experience in a wider range of analytical techniques, in 2014 she joined AstraZeneca (Cambridge, UK), as an NMR expert within the Oncology Chemistry R&D Unit. Currently, as Director of the Structural Chemistry team, Nichola is delivering analytical techniques to support small molecule structural characterisation, purity and stability assessment, in addition to NMR free ligand conformational analysis and in-cell MS concentration assays.